-
1
-
-
84862903106
-
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
-
J. R. Brahmer, S. S. Tykodi, L. Q. M. Chow et al., "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, "The New England Journal of Medicine, vol. 366, no. 26, pp. 2455-2465, 2012.
-
(2012)
The New England Journal of Medicine
, vol.366
, Issue.26
, pp. 2455-2465
-
-
Brahmer, J.R.1
Tykodi, S.S.2
Chow, L.Q.M.3
-
2
-
-
84932628341
-
PD-1 blockade in tumors with mismatch-repair deficiency
-
D. T. Le, J. N. Uram, H. Wang et al., "PD-1 blockade in tumors with mismatch-repair deficiency, " The New England Journal of Medicine, vol. 372, no. 26, pp. 2509-2520, 2015.
-
(2015)
The New England Journal of Medicine
, vol.372
, Issue.26
, pp. 2509-2520
-
-
Le, D.T.1
Uram, J.N.2
Wang, H.3
-
3
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
F. S. Hodi, S. J. ODay, D. F. McDermott et al., "Improved survival with ipilimumab in patients with metastatic melanoma, " The New England Journal of Medicine, vol. 363, no. 8, pp. 711-723, 2010.
-
(2011)
The New England Journal of Medicine
, vol.363
, Issue.8
, pp. 711-723
-
-
Hodi, F.S.1
ODay, S.J.2
McDermott, D.F.3
-
4
-
-
84879777241
-
Nivolumab plus Ipilimumab in advanced melanoma
-
J.D. Wolchok, H. Kluger, M. K. Callahan et al., "Nivolumab plus Ipilimumab in advanced melanoma, "The New England Journal of Medicine, vol. 369, no. 2, pp. 122-133, 2013.
-
(2013)
The New England Journal of Medicine
, vol.369
, Issue.2
, pp. 122-133
-
-
Wolchok, J.D.1
Kluger, H.2
Callahan, M.K.3
-
5
-
-
84877581852
-
Anti-PD-1 blockade and stereotactic radiation produce long-Term survival in mice with intracranial gliomas
-
J. Zeng, A. P. See, J. Phallen et al., "Anti-PD-1 blockade and stereotactic radiation produce long-Term survival in mice with intracranial gliomas, " International Journal of Radiation Oncology Biology Physics, vol. 86, no. 2, pp. 343-349, 2013.
-
(2013)
International Journal of Radiation Oncology Biology Physics
, vol.86
, Issue.2
, pp. 343-349
-
-
Zeng, J.1
See, A.P.2
Phallen, J.3
-
6
-
-
84899112560
-
Trial watch: Immunostimulatory monoclonal antibodies in cancer therapy
-
Article ID e27297
-
F. Aranda, E. Vacchelli, A. Eggermont et al., "Trial watch: immunostimulatory monoclonal antibodies in cancer therapy, " Oncoimmunology, vol. 3, no. 1, Article ID e27297, 2014.
-
(2014)
Oncoimmunology
, vol.3
, Issue.1
-
-
Aranda, F.1
Vacchelli, E.2
Eggermont, A.3
-
7
-
-
39149097490
-
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
-
A. B. Heimberger, W. Sun, S. F. Hussain et al., "Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study, " Neuro-Oncology, vol. 10, no. 1, pp. 98-103, 2008.
-
(2008)
Neuro-Oncology
, vol.10
, Issue.1
, pp. 98-103
-
-
Heimberger, A.B.1
Sun, W.2
Hussain, S.F.3
-
8
-
-
33748481603
-
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
-
A. El Andaloussi and M. S. Lesniak, "An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme, " Neuro-Oncology, vol. 8, no. 3, pp. 234-243, 2006.
-
(2006)
Neuro-Oncology
, vol.8
, Issue.3
, pp. 234-243
-
-
El Andaloussi, A.1
Lesniak, M.S.2
-
9
-
-
34247502076
-
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
-
P. E. Fecci, H. Ochiai, D. A. Mitchell et al., "Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function, " Clinical Cancer Research, vol. 13, no. 7, pp. 2158-2167, 2007.
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.7
, pp. 2158-2167
-
-
Fecci, P.E.1
Ochiai, H.2
Mitchell, D.A.3
-
10
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
D. I. Gabrilovich and S. Nagaraj, "Myeloid-derived suppressor cells as regulators of the immune system, " Nature Reviews Immunology, vol. 9, no. 3, pp. 162-174, 2009.
-
(2009)
Nature Reviews Immunology
, vol.9
, Issue.3
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
11
-
-
84871336215
-
The role of STAT3 activation in modulating the immune microenvironment of GBM
-
A. P. See, J. E. Han, J. Phallen et al., "The role of STAT3 activation in modulating the immune microenvironment of GBM, " Journal of Neuro-Oncology, vol. 110, no. 3, pp. 359-368, 2012.
-
(2012)
Journal of Neuro-Oncology
, vol.110
, Issue.3
, pp. 359-368
-
-
See, A.P.1
Han, J.E.2
Phallen, J.3
-
12
-
-
84862998471
-
Potential role for STAT3 inhibitors in glioblastoma
-
C. Jackson, J. Ruzevick, A. G. Amin, and M. Lim, "Potential role for STAT3 inhibitors in glioblastoma, " Neurosurgery Clinics of North America, vol. 23, no. 3, pp. 379-389, 2012.
-
(2012)
Neurosurgery Clinics of North America
, vol.23
, Issue.3
, pp. 379-389
-
-
Jackson, C.1
Ruzevick, J.2
Amin, A.G.3
Lim, M.4
-
13
-
-
34247552726
-
Stat3 as a potential target for cancer immunotherapy
-
M. Kortylewski and H. Yu, "Stat3 as a potential target for cancer immunotherapy, " Journal of Immunotherapy, vol. 30, no. 2, pp. 131-139, 2007.
-
(2007)
Journal of Immunotherapy
, vol.30
, Issue.2
, pp. 131-139
-
-
Kortylewski, M.1
Yu, H.2
-
14
-
-
84936871460
-
Structural and functional features of central nervous systemlymphatic vessels
-
A. Louveau, I. Smirnov, T. J. Keyes et al., "Structural and functional features of central nervous systemlymphatic vessels, " Nature, vol. 523, no. 7560, pp. 337-341, 2015.
-
(2015)
Nature
, vol.523
, Issue.7560
, pp. 337-341
-
-
Louveau, A.1
Smirnov, I.2
Keyes, T.J.3
-
15
-
-
0021206304
-
Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies
-
R. I. von Hanwehr, F. M. Hofman, C. R. Taylor, and M. L. J. Apuzzo, "Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies, " Journal of Neurosurgery, vol. 60, no. 6, pp. 1138-1147, 1984.
-
(1984)
Journal of Neurosurgery
, vol.60
, Issue.6
, pp. 1138-1147
-
-
Von Hanwehr, R.I.1
Hofman, F.M.2
Taylor, C.R.3
Apuzzo, M.L.J.4
-
16
-
-
0018068743
-
Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases
-
L. Palma, N. Di Lorenzo, and B. Guidetti, "Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases, " Journal of Neurosurgery, vol. 49, no. 6, pp. 854-861, 1978.
-
(1978)
Journal of Neurosurgery
, vol.49
, Issue.6
, pp. 854-861
-
-
Palma, L.1
Di Lorenzo, N.2
Guidetti, B.3
-
17
-
-
0017864016
-
Relationship of lymphocyte invasion and survival of brain tumor patients
-
W. H. Brooks, W. R. Markesbery, G. D. Gupta, and T. L. Roszman, "Relationship of lymphocyte invasion and survival of brain tumor patients, " Annals of Neurology, vol. 4, no. 3, pp. 219-224, 1978.
-
(1978)
Annals of Neurology
, vol.4
, Issue.3
, pp. 219-224
-
-
Brooks, W.H.1
Markesbery, W.R.2
Gupta, G.D.3
Roszman, T.L.4
-
18
-
-
0021151540
-
Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma
-
D. K. Boker, R. Kalff, F. Gullotta, S. Weekes-Seifert, and U. Mhrer, "Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma, " Clinical Neuropathology, vol. 3, no. 4, pp. 143-147, 1984.
-
(1984)
Clinical Neuropathology
, vol.3
, Issue.4
, pp. 143-147
-
-
Boker, D.K.1
Kalff, R.2
Gullotta, F.3
Weekes-Seifert, S.4
Mhrer, U.5
-
19
-
-
0018394501
-
Analysis of some factors effecting survival in malignant gliomas
-
D. Schiffer, D. Cavicchioli, M. T. Giordana, L. Palmucci, and A. Piazza, "Analysis of some factors effecting survival in malignant gliomas, " Tumori, vol. 65, no. 1, pp. 119-125, 1979.
-
(1979)
Tumori
, vol.65
, Issue.1
, pp. 119-125
-
-
Schiffer, D.1
Cavicchioli, D.2
Giordana, M.T.3
Palmucci, L.4
Piazza, A.5
-
20
-
-
0030853610
-
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-Associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages
-
Y.-F. Yang, J.-P. Zou, J. Mu et al., "Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-Associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages, " Cancer Research, vol. 57, no. 18, pp. 4036-4041, 1997.
-
(1997)
Cancer Research
, vol.57
, Issue.18
, pp. 4036-4041
-
-
Yang, Y.-F.1
Zou, J.-P.2
Mu, J.3
-
21
-
-
0031881906
-
Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
-
Y.-J. Kim, S. H. Kim, P. Mantel, and B. S. Kwon, "Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses, " European Journal of Immunology, vol. 28, no. 3, pp. 881-890, 1998.
-
(1998)
European Journal of Immunology
, vol.28
, Issue.3
, pp. 881-890
-
-
Kim, Y.-J.1
Kim, S.H.2
Mantel, P.3
Kwon, B.S.4
-
22
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, "Cancer immunoediting: from immunosurveillance to tumor escape, " Nature Immunology, vol. 3, no. 11, pp. 991-998, 2002.
-
(2002)
Nature Immunology
, vol.3
, Issue.11
, pp. 991-998
-
-
Dunn, G.P.1
Bruce, A.T.2
Ikeda, H.3
Old, L.J.4
Schreiber, R.D.5
-
23
-
-
79953151458
-
Cancer immunoediting: Integrating immunitys roles in cancer suppression and promotion
-
R. D. Schreiber, L. J. Old, and M. J. Smyth, "Cancer immunoediting: integrating immunitys roles in cancer suppression and promotion, " Science, vol. 331, no. 6024, pp. 1565-1570, 2011.
-
(2011)
Science
, vol.331
, Issue.6024
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
24
-
-
84859158384
-
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-Tumor immunity
-
S. L. Topalian, C. G. Drake, and D. M. Pardoll, "Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-Tumor immunity, " Current Opinion in Immunology, vol. 245, no. 2, pp. 207-212, 2012.
-
(2012)
Current Opinion in Immunology
, vol.245
, Issue.2
, pp. 207-212
-
-
Topalian, S.L.1
Drake, C.G.2
Pardoll, D.M.3
-
25
-
-
17644425689
-
The B7 family revisited
-
R. J. Greenwald, G. J. Freeman, and A.H. Sharpe, "The B7 family revisited, " Annual Review of Immunology, vol. 23, pp. 515-548, 2005.
-
(2005)
Annual Review of Immunology
, vol.23
, pp. 515-548
-
-
Greenwald, R.J.1
Freeman, G.J.2
Sharpe, A.H.3
-
26
-
-
0035757397
-
T-cell regulation by CD28 and CTLA-4
-
M.-L. Alegre, K. A. Frauwirth, and C. B. Thompson, "T-cell regulation by CD28 and CTLA-4, " Nature Reviews Immunology, vol. 1, no. 3, pp. 220-228, 2001.
-
(2001)
Nature Reviews Immunology
, vol.1
, Issue.3
, pp. 220-228
-
-
Alegre, M.-L.1
Frauwirth, K.A.2
Thompson, C.B.3
-
27
-
-
0036669785
-
The interaction properties of costimulatorymolecules revisited
-
A.V. Collins, D.W. Brodie, R. J. C. Gilbert et al., "The interaction properties of costimulatorymolecules revisited, " Immunity, vol. 17, no. 2, pp. 201-210, 2002.
-
(2002)
Immunity
, vol.17
, Issue.2
, pp. 201-210
-
-
Collins, A.V.1
Brodie, D.W.2
Gilbert, R.J.C.3
-
28
-
-
0028675006
-
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
-
P. S. Linsley, J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach, "Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors, " Immunity, vol. 1, no. 9, pp. 793-801, 1994.
-
(1994)
Immunity
, vol.1
, Issue.9
, pp. 793-801
-
-
Linsley, P.S.1
Greene, J.L.2
Brady, W.3
Bajorath, J.4
Ledbetter, J.A.5
Peach, R.6
-
29
-
-
0027937702
-
Complementarity determining region 1 (CDR1)-And CDR3-Analogous regions in CTLA-4 and CD28 determine the binding to B7-1
-
R. J. Peach, J. Bajorath, W. Brady et al., "Complementarity determining region 1 (CDR1)-And CDR3-Analogous regions in CTLA-4 and CD28 determine the binding to B7-1, " The Journal of Experimental Medicine, vol. 180, no. 6, pp. 2049-2058, 1994.
-
(1994)
The Journal of Experimental Medicine
, vol.180
, Issue.6
, pp. 2049-2058
-
-
Peach, R.J.1
Bajorath, J.2
Brady, W.3
-
30
-
-
0027282960
-
Characterization of CTLA-4 structure and expression on human T cells
-
T. Lindsten, K. P. Lee, E. S. Harris et al., "Characterization of CTLA-4 structure and expression on human T cells, " The Journal of Immunology, vol. 151, no. 7, pp. 3489-3499, 1993.
-
(1993)
The Journal of Immunology
, vol.151
, Issue.7
, pp. 3489-3499
-
-
Lindsten, T.1
Lee, K.P.2
Harris, E.S.3
-
31
-
-
65349119978
-
CD28 and CTLA-4 coreceptor expression and signal transduction
-
C. E. Rudd, A. Taylor, and H. Schneider, "CD28 and CTLA-4 coreceptor expression and signal transduction, " Immunological Reviews, vol. 229, no. 1, pp. 12-26, 2009.
-
(2009)
Immunological Reviews
, vol.229
, Issue.1
, pp. 12-26
-
-
Rudd, C.E.1
Taylor, A.2
Schneider, H.3
-
32
-
-
0033662376
-
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
-
E. Chuang, T. S. Fisher, R. W. Morgan et al., "The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A, " Immunity, vol. 13, no. 3, pp. 313-322, 2000.
-
(2000)
Immunity
, vol.13
, Issue.3
, pp. 313-322
-
-
Chuang, E.1
Fisher, T.S.2
Morgan, R.W.3
-
33
-
-
0033048961
-
CTLA4 ligation attenuates AP-1, NFAT and NF-B activity in activated T cells
-
J.H. Fraser, M. Rincn, K. D. McCoy, and G. L. Gros, "CTLA4 ligation attenuates AP-1, NFAT and NF-B activity in activated T cells, " European Journal of Immunology, vol. 29, no. 3, pp. 838-844, 1999.
-
(1999)
European Journal of Immunology
, vol.29
, Issue.3
, pp. 838-844
-
-
Fraser, J.H.1
Rincn, M.2
McCoy, K.D.3
Gros, G.L.4
-
34
-
-
79954459308
-
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family
-
H. Bour-Jordan, J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone, "Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family, " Immunological Reviews, vol. 241, no. 1, pp. 180-205, 2011.
-
(2011)
Immunological Reviews
, vol.241
, Issue.1
, pp. 180-205
-
-
Bour-Jordan, H.1
Esensten, J.H.2
Martinez-Llordella, M.3
Penaranda, C.4
Stumpf, M.5
Bluestone, J.A.6
-
35
-
-
0037244012
-
Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-Associated antigen 4
-
S. Chikuma, J. B. Imboden, and J. A. Bluestone, "Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-Associated antigen 4, " The Journal of Experimental Medicine, vol. 197, no. 1, pp. 129-135, 2003.
-
(2003)
The Journal of Experimental Medicine
, vol.197
, Issue.1
, pp. 129-135
-
-
Chikuma, S.1
Imboden, J.B.2
Bluestone, J.A.3
-
36
-
-
0035803552
-
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function
-
M. Martin, H. Schneider, A. Azouz, and C. E. Rudd, "Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function, " Journal of Experimental Medicine, vol. 194, no. 11, pp. 1675-1681, 2001.
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.11
, pp. 1675-1681
-
-
Martin, M.1
Schneider, H.2
Azouz, A.3
Rudd, C.E.4
-
37
-
-
38349074305
-
CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization
-
H. Schneider, X. Smith, H. Liu, G. Bismuth, and C. E. Rudd, "CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization, " European Journal of Immunology, vol. 38, no. 1, pp. 40-47, 2008.
-
(2008)
European Journal of Immunology
, vol.38
, Issue.1
, pp. 40-47
-
-
Schneider, H.1
Smith, X.2
Liu, H.3
Bismuth, G.4
Rudd, C.E.5
-
38
-
-
0035869583
-
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-Transgenic T cells: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
-
T. F. Gajewski, F. Fallarino, P. E. Fields, F. Rivas, and M.-L. Alegre, "Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-Transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase, " The Journal of Immunology, vol. 166, no. 6, pp. 3900-3907, 2001.
-
(2001)
The Journal of Immunology
, vol.166
, Issue.6
, pp. 3900-3907
-
-
Gajewski, T.F.1
Fallarino, F.2
Fields, P.E.3
Rivas, F.4
Alegre, M.-L.5
-
39
-
-
0030443168
-
Regulation of surface and intracellular expression of CTLA4 on mouse T cells
-
M.-L. Alegre, P. J. Noel, B. J. Eisfelder et al., "Regulation of surface and intracellular expression of CTLA4 on mouse T cells, " Journal of Immunology, vol. 157, no. 11, pp. 4762-4770, 1996.
-
(1996)
Journal of Immunology
, vol.157
, Issue.11
, pp. 4762-4770
-
-
Alegre, M.-L.1
Noel, P.J.2
Eisfelder, B.J.3
-
40
-
-
79955529454
-
Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4
-
O. S. Qureshi, Y. Zheng, K. Nakamura et al., "Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4, " Science, vol. 332, no. 6029, pp. 600-603, 2011.
-
(2011)
Science
, vol.332
, Issue.6029
, pp. 600-603
-
-
Qureshi, O.S.1
Zheng, Y.2
Nakamura, K.3
-
41
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
D. M. Pardoll, "The blockade of immune checkpoints in cancer immunotherapy, " Nature Reviews Cancer, vol. 12, no. 4, pp. 252-264, 2012.
-
(2012)
Nature Reviews Cancer
, vol.12
, Issue.4
, pp. 252-264
-
-
Pardoll, D.M.1
-
42
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
-
P. Waterhouse, J.M. Penninger, E. Timms et al., "Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, " Science, vol. 270, no. 5238, pp. 985-988, 1995.
-
(1995)
Science
, vol.270
, Issue.5238
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
-
43
-
-
0031405867
-
Lymphoproliferation inCTLA-4-deficient mice ismediated by costimulationdependent activation of CD4+ T cells
-
C.A. Chambers, T. J. Sullivan, and J. P. Allison, "Lymphoproliferation inCTLA-4-deficient mice ismediated by costimulationdependent activation of CD4+ T cells, " Immunity, vol. 7, no. 6, pp. 885-895, 1997.
-
(1997)
Immunity
, vol.7
, Issue.6
, pp. 885-895
-
-
Chambers, C.A.1
Sullivan, T.J.2
Allison, J.P.3
-
44
-
-
0035059417
-
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
-
B. Salomon and J. A. Bluestone, "Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation, " Annual Review of Immunology, vol. 19, pp. 225-252, 2001.
-
(2001)
Annual Review of Immunology
, vol.19
, pp. 225-252
-
-
Salomon, B.1
Bluestone, J.A.2
-
45
-
-
0031278368
-
T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors
-
L. A. Morford, L. H. Elliott, S. L. Carlson, W. H. Brooks, and T. L. Roszman, "T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors, " Journal of Immunology, vol. 159, no. 9, pp. 4415-4425, 1997.
-
(1997)
Journal of Immunology
, vol.159
, Issue.9
, pp. 4415-4425
-
-
Morford, L.A.1
Elliott, L.H.2
Carlson, S.L.3
Brooks, W.H.4
Roszman, T.L.5
-
46
-
-
0018832524
-
Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours
-
T. L. Roszman and W. H. Brooks, "Immunobiology of primary intracranial tumours. III. demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours, " Clinical&Experimental Immunology, vol. 39, no. 2, pp. 395-402, 1980.
-
(1980)
Clinical&Experimental Immunology
, vol.39
, Issue.2
, pp. 395-402
-
-
Roszman, T.L.1
Brooks, W.H.2
-
47
-
-
22144485870
-
Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection
-
M. A. Hughes, M. Parisi, S. Grossman, and L. Kleinberg, "Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection, " International Journal of RadiationOncology Biology Physics, vol. 62, no. 5, pp. 1423-1426, 2005.
-
(2005)
International Journal of RadiationOncology Biology Physics
, vol.62
, Issue.5
, pp. 1423-1426
-
-
Hughes, M.A.1
Parisi, M.2
Grossman, S.3
Kleinberg, L.4
-
48
-
-
0141891466
-
Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers
-
F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii, "Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers, " Clinical Cancer Research, vol. 9, no. 12, pp. 4404-4408, 2003.
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.12
, pp. 4404-4408
-
-
Ichihara, F.1
Kono, K.2
Takahashi, A.3
Kawaida, H.4
Sugai, H.5
Fujii, H.6
-
49
-
-
27644593923
-
Human CTLA4 knockin mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies
-
K. D. Lute, K. F. May Jr., P. Lu et al., "Human CTLA4 knockin mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies, " Blood, vol. 106, no. 9, pp. 3127-3133, 2005.
-
(2005)
Blood
, vol.106
, Issue.9
, pp. 3127-3133
-
-
Lute, K.D.1
May, K.F.2
Lu, P.3
-
50
-
-
0036721629
-
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
-
U. K. Liyanage, T. T. Moore, H.-G. Joo et al., "Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, "TheJournal of Immunology, vol. 169, no. 5, pp. 2756-2761, 2002.
-
(2002)
The Journal of Immunology
, vol.169
, Issue.5
, pp. 2756-2761
-
-
Liyanage, U.K.1
Moore, T.T.2
Joo, H.-G.3
-
51
-
-
0041386189
-
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression
-
T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi, "CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression, " Cancer, vol. 98, no. 5, pp. 1089-1099, 2003.
-
(2003)
Cancer
, vol.98
, Issue.5
, pp. 1089-1099
-
-
Sasada, T.1
Kimura, M.2
Yoshida, Y.3
Kanai, M.4
Takabayashi, A.5
-
52
-
-
0035874949
-
Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
-
E. Y. Woo, C. S. Chu, T. J. Goletz et al., "Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, " Cancer Research, vol. 61, no. 12, pp. 4766-4772, 2001.
-
(2001)
Cancer Research
, vol.61
, Issue.12
, pp. 4766-4772
-
-
Woo, E.Y.1
Chu, C.S.2
Goletz, T.J.3
-
53
-
-
33645502885
-
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
-
P. E. Fecci, D. A. Mitchell, J. F. Whitesides et al., "Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma, " Cancer Research, vol. 66, no. 6, pp. 3294-3302, 2006.
-
(2006)
Cancer Research
, vol.66
, Issue.6
, pp. 3294-3302
-
-
Fecci, P.E.1
Mitchell, D.A.2
Whitesides, J.F.3
-
54
-
-
34248172651
-
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo
-
O. M. Grauer, S. Nierkens, E. Bennink et al., "CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo, " International Journal of Cancer, vol. 121, no. 1, pp. 95-105, 2007.
-
(2007)
International Journal of Cancer
, vol.121
, Issue.1
, pp. 95-105
-
-
Grauer, O.M.1
Nierkens, S.2
Bennink, E.3
-
55
-
-
84861233216
-
Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors
-
P. Agarwalla, Z. Barnard, P. Fecci, G. Dranoff, and W. T. Curry Jr., "Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors, " Journal of Immunotherapy, vol. 35, no. 5, pp. 385-389, 2012.
-
(2012)
Journal of Immunotherapy
, vol.35
, Issue.5
, pp. 385-389
-
-
Agarwalla, P.1
Barnard, Z.2
Fecci, P.3
Dranoff, G.4
Curry, W.T.5
-
56
-
-
84876678621
-
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma
-
J. S. Weber, R. Dummer, V. de Pril, C. Lebb, and F. S. Hodi, "Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma, " Cancer, vol. 119, no. 9, pp. 1675-1682, 2013.
-
(2013)
Cancer
, vol.119
, Issue.9
, pp. 1675-1682
-
-
Weber, J.S.1
Dummer, R.2
De Pril, V.3
Lebb, C.4
Hodi, F.S.5
-
57
-
-
84871617507
-
Diagnostic and therapeutic avenues for glioblastoma: No longer a dead end?
-
S. Tanaka, D. N. Louis, W. T. Curry, T. T. Batchelor, and J. Dietrich, "Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?" Nature Reviews Clinical Oncology, vol. 10, no. 1, pp. 14-26, 2013.
-
(2013)
Nature Reviews Clinical Oncology
, vol.10
, Issue.1
, pp. 14-26
-
-
Tanaka, S.1
Louis, D.N.2
Curry, W.T.3
Batchelor, T.T.4
Dietrich, J.5
-
58
-
-
0032736029
-
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
-
H. Dong, G. Zhu, K. Tamada, and L. Chen, "B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, " Nature Medicine, vol. 5, no. 12, pp. 1365-1369, 1999.
-
(1999)
Nature Medicine
, vol.5
, Issue.12
, pp. 1365-1369
-
-
Dong, H.1
Zhu, G.2
Tamada, K.3
Chen, L.4
-
59
-
-
5844264920
-
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
-
Y. Latchman, C. R. Wood, T. Chernova et al., "PD-L2 is a second ligand for PD-1 and inhibits T cell activation, " Nature Immunology, vol. 2, no. 3, pp. 261-268, 2001.
-
(2001)
Nature Immunology
, vol.2
, Issue.3
, pp. 261-268
-
-
Latchman, Y.1
Wood, C.R.2
Chernova, T.3
-
60
-
-
0027513170
-
-
K. W. Moore, A. OGarra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann, "Interleukin-10, " Annual Review of Immunology, vol. 11, pp. 165-190, 1993.
-
(1993)
Interleukin-10 Annual Review of Immunology
, vol.11
, pp. 165-190
-
-
Moore, K.W.1
OGarra, A.2
Malefyt Waal, R.3
Vieira, P.4
Mosmann, T.R.5
-
61
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, "PD-1 and its ligands in tolerance and immunity, " Annual Review of Immunology, vol. 26, pp. 677-704, 2008.
-
(2008)
Annual Review of Immunology
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
62
-
-
84863089861
-
Selective effects of PD-1 on Akt and ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation
-
article ra46
-
N. Patsoukis, J. Brown, V. Petkova, F. Liu, L. Li, and V. A. Boussiotis, "Selective effects of PD-1 on Akt and ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation, " Science Signaling, vol. 5, no. 230, article ra46, 2012.
-
(2012)
Science Signaling
, vol.5
, Issue.230
-
-
Patsoukis, N.1
Brown, J.2
Petkova, V.3
Liu, F.4
Li, L.5
Boussiotis, V.A.6
-
63
-
-
33645846313
-
Tissue expressionof PDL1 mediates peripheral T cell tolerance
-
M.E. Keir, S. C. Liang, I. Guleria et al., "Tissue expressionof PDL1 mediates peripheral T cell tolerance, " Journal of Experimental Medicine, vol. 203, no. 4, pp. 883-895, 2006.
-
(2006)
Journal of Experimental Medicine
, vol.203
, Issue.4
, pp. 883-895
-
-
Keir, M.E.1
Liang, S.C.2
Guleria, I.3
-
64
-
-
27144496045
-
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
-
R. V. Parry, J. M. Chemnitz, K. A. Frauwirth et al., "CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, "Molecular and Cellular Biology, vol. 25, no. 21, pp. 9543-9553, 2005.
-
(2005)
Molecular and Cellular Biology
, vol.25
, Issue.21
, pp. 9543-9553
-
-
Parry, R.V.1
Chemnitz, J.M.2
Frauwirth, K.A.3
-
65
-
-
0034596948
-
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 familymember leads to negative regulation of lymphocyte activation
-
G. J. Freeman, A. J. Long, Y. Iwai et al., "Engagement of the PD-1 immunoinhibitory receptor by a novel B7 familymember leads to negative regulation of lymphocyte activation, " The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1027-1034, 2000.
-
(2000)
The Journal of Experimental Medicine
, vol.192
, Issue.7
, pp. 1027-1034
-
-
Freeman, G.J.1
Long, A.J.2
Iwai, Y.3
-
66
-
-
0036207926
-
PD-1:PD-L inhibitory pathway affects bothCD4+ andCD8+ Tcells and is overcome by IL-2
-
L. Carter, L. A. Fouser, J. Jussif et al., "PD-1:PD-L inhibitory pathway affects bothCD4+ andCD8+ Tcells and is overcome by IL-2, " European Journal of Immunology, vol. 32, no. 3, pp. 634-643, 2002.
-
(2002)
European Journal of Immunology
, vol.32
, Issue.3
, pp. 634-643
-
-
Carter, L.1
Fouser, L.A.2
Jussif, J.3
-
67
-
-
0242442492
-
Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysis
-
S. Wintterle, B. Schreiner, M. Mitsdoerffer et al., "Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysis, " Cancer Research, vol. 63, no. 21, pp. 7462-7467, 2003.
-
(2003)
Cancer Research
, vol.63
, Issue.21
, pp. 7462-7467
-
-
Wintterle, S.1
Schreiner, B.2
Mitsdoerffer, M.3
-
68
-
-
33846118474
-
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
-
A. T. Parsa, J. S. Waldron, A. Panner et al., "Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, " Nature Medicine, vol. 13, no. 1, pp. 84-88, 2007.
-
(2007)
Nature Medicine
, vol.13
, Issue.1
, pp. 84-88
-
-
Parsa, A.T.1
Waldron, J.S.2
Panner, A.3
-
69
-
-
77955665451
-
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions
-
T. Avril, S. Saikali, E. Vauleon et al., "Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions, " Journal of Neuroimmunology, vol. 225, no. 1-2, pp. 22-33, 2010.
-
(2011)
Journal of Neuroimmunology
, vol.225
, Issue.1-2
, pp. 22-33
-
-
Avril, T.1
Saikali, S.2
Vauleon, E.3
-
70
-
-
68949085209
-
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
-
J. F.M. Jacobs, A. J. Idema, K. F. Bol et al., "Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors, " Neuro-Oncology, vol. 11, no. 4, pp. 394-402, 2009.
-
(2009)
Neuro-Oncology
, vol.11
, Issue.4
, pp. 394-402
-
-
Jacobs, J.F.M.1
Idema, A.J.2
Bol, K.F.3
-
71
-
-
22544486023
-
B7-homolog 1 expression by human glioma: A new mechanism of immune evasion
-
R. Wilmotte, K. Burkhardt, V. Kindler et al., "B7-homolog 1 expression by human glioma: A new mechanism of immune evasion, " Neuroreport, vol. 16, no. 10, pp. 1081-1085, 2005.
-
(2005)
Neuroreport
, vol.16
, Issue.10
, pp. 1081-1085
-
-
Wilmotte, R.1
Burkhardt, K.2
Kindler, V.3
-
72
-
-
9144255487
-
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)
-
N. Li, C. J. Workman, S. M. Martin, and D. A. A. Vignali, "Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223), "The Journal of Immunology, vol. 173, no. 11, pp. 6806-6812, 2004.
-
(2004)
The Journal of Immunology
, vol.173
, Issue.11
, pp. 6806-6812
-
-
Li, N.1
Workman, C.J.2
Martin, S.M.3
Vignali, D.A.A.4
-
73
-
-
0038068048
-
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated Tcells
-
C. J. Workman and D. A. A. Vignali, "The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated Tcells, " European Journal of Immunology, vol. 33, no. 4, pp. 970-979, 2003.
-
(2003)
European Journal of Immunology
, vol.33
, Issue.4
, pp. 970-979
-
-
Workman, C.J.1
Vignali, D.A.A.2
-
74
-
-
0032532284
-
CD3/TCR complex-Associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling
-
S. Hannier, M. Tournier, G. Bismuth, and F. Triebel, "CD3/TCR complex-Associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling, " The Journal of Immunology, vol. 161, no. 8, pp. 4058-4065, 1998.
-
(1998)
The Journal of Immunology
, vol.161
, Issue.8
, pp. 4058-4065
-
-
Hannier, S.1
Tournier, M.2
Bismuth, G.3
Triebel, F.4
-
75
-
-
0344440962
-
LAG-3: A regulator of T-cell and DC responses and its use in therapeutic vaccination
-
F. Triebel, "LAG-3: A regulator of T-cell and DC responses and its use in therapeutic vaccination, " Trends in Immunology, vol. 24, no. 12, pp. 619-622, 2003.
-
(2003)
Trends in Immunology
, vol.24
, Issue.12
, pp. 619-622
-
-
Triebel, F.1
-
76
-
-
0037090060
-
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)
-
S. Andreae, F. Piras, N. Burdin, and F. Triebel, "Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223), " The Journal of Immunology, vol. 168, no. 8, pp. 3874-3880, 2002.
-
(2002)
The Journal of Immunology
, vol.168
, Issue.8
, pp. 3874-3880
-
-
Andreae, S.1
Piras, F.2
Burdin, N.3
Triebel, F.4
-
77
-
-
9344236517
-
Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-production
-
F. Annunziato, R. Manetti, L. Tomasvic et al., "Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-production, " The FASEB Journal, vol. 10, no. 7, pp. 769-776, 1996.
-
(1996)
The FASEB Journal
, vol.10
, Issue.7
, pp. 769-776
-
-
Annunziato, F.1
Manetti, R.2
Tomasvic, L.3
-
78
-
-
5644263642
-
Role of LAG-3 in regulatory T cells
-
C.-T. Huang, C. J. Workman, D. Flies et al., "Role of LAG-3 in regulatory T cells, " Immunity, vol. 21, no. 4, pp. 503-513, 2004.
-
(2004)
Immunity
, vol.21
, Issue.4
, pp. 503-513
-
-
Huang, C.-T.1
Workman, C.J.2
Flies, D.3
-
80
-
-
36048963838
-
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self-And tumor-Tolerance systems
-
J. F. Grosso, C. C. Kelleher, T. J. Harris et al., "LAG-3 regulates CD8+ T cell accumulation and effector function in murine self-And tumor-Tolerance systems, " The Journal of Clinical Investigation, vol. 117, no. 11, pp. 3383-3392, 2007.
-
(2007)
The Journal of Clinical Investigation
, vol.117
, Issue.11
, pp. 3383-3392
-
-
Grosso, J.F.1
Kelleher, C.C.2
Harris, T.J.3
-
81
-
-
84863115998
-
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
-
S.-R. Woo, M. E. Turnis, M. V. Goldberg et al., "Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape, " Cancer Research, vol. 72, no. 4, pp. 917-927, 2012.
-
(2012)
Cancer Research
, vol.72
, Issue.4
, pp. 917-927
-
-
Woo, S.-R.1
Turnis, M.E.2
Goldberg, M.V.3
-
82
-
-
79960918412
-
Emerging Tim-3 functions in antimicrobial and tumor immunity
-
K. Sakuishi, P. Jayaraman, S. M. Behar, A. C. Anderson, and V. K. Kuchroo, "Emerging Tim-3 functions in antimicrobial and tumor immunity, " Trends in Immunology, vol. 32, no. 8, pp. 345-349, 2011.
-
(2011)
Trends in Immunology
, vol.32
, Issue.8
, pp. 345-349
-
-
Sakuishi, K.1
Jayaraman, P.2
Behar, S.M.3
Anderson, A.C.4
Kuchroo, V.K.5
-
83
-
-
79955959750
-
TIM-3 and its regulatory role in immune responses
-
C. Zhu, A. C. Anderson, and V. K. Kuchroo, "TIM-3 and its regulatory role in immune responses, " Current Topics in Microbiology and Immunology, vol. 350, pp. 1-15, 2011.
-
(2011)
Current Topics in Microbiology and Immunology
, vol.350
, pp. 1-15
-
-
Zhu, C.1
Anderson, A.C.2
Kuchroo, V.K.3
-
84
-
-
0031048272
-
Identification and characterization of galectin-9, a novel-galactoside-bindingmammalian lectin
-
J. Wada and Y. S. Kanwar, "Identification and characterization of galectin-9, a novel-galactoside-bindingmammalian lectin, " The Journal of Biological Chemistry, vol. 272, no. 9, pp. 6078-6086, 1997.
-
(1997)
The Journal of Biological Chemistry
, vol.272
, Issue.9
, pp. 6078-6086
-
-
Wada, J.1
Kanwar, Y.S.2
-
85
-
-
30044434075
-
The tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
-
C. Zhu, A. C. Anderson, A. Schubart et al., "The tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity, " Nature Immunology, vol. 6, no. 12, pp. 1245-1252, 2005.
-
(2005)
Nature Immunology
, vol.6
, Issue.12
, pp. 1245-1252
-
-
Zhu, C.1
Anderson, A.C.2
Schubart, A.3
-
86
-
-
79955977180
-
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acutemyelogenous leukemia
-
Q. Zhou, M. E. Munger, R. G. Veenstra et al., "Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acutemyelogenous leukemia, " Blood, vol. 117, no. 17, pp. 4501-4510, 2011.
-
(2011)
Blood
, vol.117
, Issue.17
, pp. 4501-4510
-
-
Zhou, Q.1
Munger, M.E.2
Veenstra, R.G.3
-
87
-
-
69449091993
-
Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells
-
L. Golden-Mason, B. E. Palmer, N. Kassam et al., "Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells, " Journal of Virology, vol. 83, no. 18, pp. 9122-9130, 2009.
-
(2009)
Journal of Virology
, vol.83
, Issue.18
, pp. 9122-9130
-
-
Golden-Mason, L.1
Palmer, B.E.2
Kassam, N.3
-
88
-
-
78649903057
-
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
-
R. H. McMahan, L. Golden-Mason, M. I. Nishimura et al., "Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity, "The Journal of Clinical Investigation, vol. 120, no. 12, pp. 4546-4557, 2010.
-
(2011)
The Journal of Clinical Investigation
, vol.120
, Issue.12
, pp. 4546-4557
-
-
McMahan, R.H.1
Golden-Mason, L.2
Nishimura, M.I.3
-
89
-
-
77957059176
-
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
-
H.-T. Jin, A. C. Anderson, W. G. Tan et al., "Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14733-14738, 2010.
-
(2011)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, Issue.33
, pp. 14733-14738
-
-
Jin, H.-T.1
Anderson, A.C.2
Tan, W.G.3
-
90
-
-
77957723967
-
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigenspecific CD8+ T cell dysfunction in melanoma patients
-
J. Fourcade, Z. Sun, M. Benallaoua et al., "Upregulation of Tim-3 and PD-1 expression is associated with tumor antigenspecific CD8+ T cell dysfunction in melanoma patients, " Journal of Experimental Medicine, vol. 207, no. 10, pp. 2175-2186, 2010.
-
(2011)
Journal of Experimental Medicine
, vol.207
, Issue.10
, pp. 2175-2186
-
-
Fourcade, J.1
Sun, Z.2
Benallaoua, M.3
-
91
-
-
77957744369
-
Targeting tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-Tumor immunity
-
K. Sakuishi, L. Apetoh, J. M. Sullivan, B. R. Blazar, V. K. Kuchroo, and A. C. Anderson, "Targeting tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-Tumor immunity, " Journal of Experimental Medicine, vol. 207, no. 10, pp. 2187-2194, 2010.
-
(2011)
Journal of Experimental Medicine
, vol.207
, Issue.10
, pp. 2187-2194
-
-
Sakuishi, K.1
Apetoh, L.2
Sullivan, J.M.3
Blazar, B.R.4
Kuchroo, V.K.5
Anderson, A.C.6
-
92
-
-
77956409684
-
Tim-3/galectin-9 pathway: Regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells
-
V. Dardalhon, A. C. Anderson, J. Karman et al., "Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells, " The Journal of Immunology, vol. 185, no. 3, pp. 1383-1392, 2010.
-
(2011)
The Journal of Immunology
, vol.185
, Issue.3
, pp. 1383-1392
-
-
Dardalhon, V.1
Anderson, A.C.2
Karman, J.3
-
93
-
-
0033588952
-
In vivo expression of natural killer cell inhibitory receptors by human melanomaspecific cytolytic T lymphocytes
-
D. E. Speiser, M. J. Pittet, D. Valmori et al., "In vivo expression of natural killer cell inhibitory receptors by human melanomaspecific cytolytic T lymphocytes, " The Journal of Experimental Medicine, vol. 190, no. 6, pp. 775-782, 1999.
-
(1999)
The Journal of Experimental Medicine
, vol.190
, Issue.6
, pp. 775-782
-
-
Speiser, D.E.1
Pittet, M.J.2
Valmori, D.3
-
94
-
-
0031046201
-
Killer cell inhibitory receptors: Diversity, specificity, and function
-
E. O. Long, D. N. Burshtyn, W. P. Clark et al., "Killer cell inhibitory receptors: diversity, specificity, and function, " Immunological Reviews, vol. 155, pp. 135-144, 1997.
-
(1997)
Immunological Reviews
, vol.155
, pp. 135-144
-
-
Long, E.O.1
Burshtyn, D.N.2
Clark, W.P.3
-
95
-
-
0030024788
-
Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor
-
D. N. Burshtyn, A. M. Scharenberg, N. Wagtmann et al., "Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor, " Immunity, vol. 4, no. 1, pp. 77-85, 1996.
-
(1996)
Immunity
, vol.4
, Issue.1
, pp. 77-85
-
-
Burshtyn, D.N.1
Scharenberg, A.M.2
Wagtmann, N.3
-
96
-
-
0030470555
-
Human natural killer cell receptors involved in MHC class i recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
-
S. Lazetic, C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips, "Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits, " Journal of Immunology, vol. 157, no. 11, pp. 4741-4745, 1996.
-
(1996)
Journal of Immunology
, vol.157
, Issue.11
, pp. 4741-4745
-
-
Lazetic, S.1
Chang, C.2
Houchins, J.P.3
Lanier, L.L.4
Phillips, J.H.5
-
97
-
-
0030039386
-
The human leukocyte antigen (HLA)-C-specific activatory or inhibitory natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
-
R. Biassoni, C. Cantoni, M. Falco et al., "The human leukocyte antigen (HLA)-C-specific activatory or inhibitory natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions, " Journal of Experimental Medicine, vol. 183, no. 2, pp. 645-650, 1996.
-
(1996)
Journal of Experimental Medicine
, vol.183
, Issue.2
, pp. 645-650
-
-
Biassoni, R.1
Cantoni, C.2
Falco, M.3
-
98
-
-
0029015726
-
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-And intracellular domains
-
N. Wagtmann, R. Biassoni, C. Cantoni et al., "Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-And intracellular domains, " Immunity, vol. 2, no. 5, pp. 439-449, 1995.
-
(1995)
Immunity
, vol.2
, Issue.5
, pp. 439-449
-
-
Wagtmann, N.1
Biassoni, R.2
Cantoni, C.3
-
99
-
-
0036945657
-
The killer cell immunoglobulin-like receptor (KIR) genomic region: Geneorder, haplotypes and allelic polymorphism
-
K. C. Hsu, S. Chida, D. E. Geraghty, and B. Dupont, "The killer cell immunoglobulin-like receptor (KIR) genomic region: geneorder, haplotypes and allelic polymorphism, " Immunological Reviews, vol. 190, pp. 40-52, 2002.
-
(2002)
Immunological Reviews
, vol.190
, pp. 40-52
-
-
Hsu, K.C.1
Chida, S.2
Geraghty, D.E.3
Dupont, B.4
-
100
-
-
79951953456
-
Activating and inhibitory receptors of natural killer cells
-
H. J. Pegram, D. M. Andrews, M. J. Smyth, P. K. Darcy, and M.H. Kershaw, "Activating and inhibitory receptors of natural killer cells, " Immunology and Cell Biology, vol. 89, no. 2, pp. 216-224, 2011.
-
(2011)
Immunology and Cell Biology
, vol.89
, Issue.2
, pp. 216-224
-
-
Pegram, H.J.1
Andrews, D.M.2
Smyth, M.J.3
Darcy, P.K.4
Kershaw, M.H.5
-
101
-
-
42949129193
-
HLA alleles determine differences in human natural killer cell responsiveness and potency
-
S. Kim, J. B. Sunwoo, L. Yang et al., "HLA alleles determine differences in human natural killer cell responsiveness and potency, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 3053-3058, 2008.
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.8
, pp. 3053-3058
-
-
Kim, S.1
Sunwoo, J.B.2
Yang, L.3
-
102
-
-
65549133016
-
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation
-
J. Yu, J. M. Venstrom, X.-R. Liu et al., "Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation, " Blood, vol. 113, no. 16, pp. 3875-3884, 2009.
-
(2009)
Blood
, vol.113
, Issue.16
, pp. 3875-3884
-
-
Yu, J.1
Venstrom, J.M.2
Liu, X.-R.3
-
103
-
-
34247595404
-
Prospects for the use of NK cells in immunotherapy of human cancer
-
H.-G. Ljunggren and K.-J. Malmberg, "Prospects for the use of NK cells in immunotherapy of human cancer, " Nature Reviews Immunology, vol. 7, no. 5, pp. 329-339, 2007.
-
(2007)
Nature Reviews Immunology
, vol.7
, Issue.5
, pp. 329-339
-
-
Ljunggren, H.-G.1
Malmberg, K.-J.2
-
104
-
-
1542380606
-
Unravelling natural killer cell function: Triggering and inhibitory human NK receptors
-
L. Moretta and A. Moretta, "Unravelling natural killer cell function: Triggering and inhibitory human NK receptors, " The EMBO Journal, vol. 23, no. 2, pp. 255-259, 2004.
-
(2004)
The EMBO Journal
, vol.23
, Issue.2
, pp. 255-259
-
-
Moretta, L.1
Moretta, A.2
-
105
-
-
36549023879
-
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
-
L. Ruggeri, A. Mancusi, E. Burchielli et al., "NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation, " Blood Cells, Molecules, and Diseases, vol. 40, no. 1, pp. 84-90, 2008.
-
(2008)
Blood Cells, Molecules, and Diseases
, vol.40
, Issue.1
, pp. 84-90
-
-
Ruggeri, L.1
Mancusi, A.2
Burchielli, E.3
-
106
-
-
20144388509
-
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
-
J. S. Miller, Y. Soignier, A. Panoskaltsis-Mortari et al., "Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, " Blood, vol. 105, no. 8, pp. 3051-3057, 2005.
-
(2005)
Blood
, vol.105
, Issue.8
, pp. 3051-3057
-
-
Miller, J.S.1
Soignier, Y.2
Panoskaltsis-Mortari, A.3
-
107
-
-
0025300414
-
In search of the missing self : MHC molecules and NK cell recognition
-
H.-G. Ljunggren and K. Krre, "In search of the missing self : MHC molecules and NK cell recognition, " Immunology Today, vol. 11, no. 7, pp. 237-244, 1990.
-
(1990)
Immunology Today
, vol.11
, Issue.7
, pp. 237-244
-
-
Ljunggren, H.-G.1
Krre, K.2
-
108
-
-
0022317963
-
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
-
H.-G. Ljunggren and K. Karre, "Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism, "The Journal of Experimental Medicine, vol. 162, no. 6, pp. 1745-1759, 1985.
-
(1985)
The Journal of Experimental Medicine
, vol.162
, Issue.6
, pp. 1745-1759
-
-
Ljunggren, H.-G.1
Karre, K.2
-
109
-
-
0022616253
-
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
-
K. Karre, H. G. Ljunggren, G. Piontek, and R. Kiessling, "Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, " Nature, vol. 319, no. 6055, pp. 675-678, 1986.
-
(1986)
Nature
, vol.319
, Issue.6055
, pp. 675-678
-
-
Karre, K.1
Ljunggren, H.G.2
Piontek, G.3
Kiessling, R.4
-
110
-
-
10744230735
-
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
-
S. Giebel, F. Locatelli, T. Lamparelli et al., "Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors, " Blood, vol. 102, no. 3, pp. 814-819, 2003.
-
(2003)
Blood
, vol.102
, Issue.3
, pp. 814-819
-
-
Giebel, S.1
Locatelli, F.2
Lamparelli, T.3
-
111
-
-
15244346488
-
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-Term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
-
D. W. Beelen, H. D. Ottinger, S. Ferencik et al., "Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-Term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias, " Blood, vol. 105, no. 6, pp. 2594-2600, 2005.
-
(2005)
Blood
, vol.105
, Issue.6
, pp. 2594-2600
-
-
Beelen, D.W.1
Ottinger, H.D.2
Ferencik, S.3
-
112
-
-
34247581578
-
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
-
J. S. Miller, S. Cooley, P. Parham et al., "Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT, " Blood, vol. 109, no. 11, pp. 5058-5061, 2007.
-
(2007)
Blood
, vol.109
, Issue.11
, pp. 5058-5061
-
-
Miller, J.S.1
Cooley, S.2
Parham, P.3
-
113
-
-
0042194439
-
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
-
Y. K. Tam, J. A. Martinson, K. Doligosa, and H.-G. Klingemann, "Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy, " Cytotherapy, vol. 5, no. 3, pp. 259-272, 2003.
-
(2003)
Cytotherapy
, vol.5
, Issue.3
, pp. 259-272
-
-
Tam, Y.K.1
Martinson, J.A.2
Doligosa, K.3
Klingemann, H.-G.4
-
114
-
-
17444414991
-
Natural killer cell-based immunotherapeutic strategies
-
H.-G. Klingemann, "Natural killer cell-based immunotherapeutic strategies, " Cytotherapy, vol. 7, no. 1, pp. 16-22, 2005.
-
(2005)
Cytotherapy
, vol.7
, Issue.1
, pp. 16-22
-
-
Klingemann, H.-G.1
-
115
-
-
84894030202
-
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
-
H. E. Kohrt, A. Thielens, A. Marabelle et al., "Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies, " Blood, vol. 123, no. 5, pp. 678-686, 2014.
-
(2014)
Blood
, vol.123
, Issue.5
, pp. 678-686
-
-
Kohrt, H.E.1
Thielens, A.2
Marabelle, A.3
-
116
-
-
69249108787
-
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
-
F. Romagn, P. Andr, P. Spee et al., "Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells, " Blood, vol. 114, no. 13, pp. 2667-2677, 2009.
-
(2009)
Blood
, vol.114
, Issue.13
, pp. 2667-2677
-
-
Romagn, F.1
Andr, P.2
Spee, P.3
-
117
-
-
0035874543
-
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
-
C. Y. Koh, B. R. Blazar, T. George et al., "Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo, " Blood, vol. 97, no. 10, pp. 3132-3137, 2001.
-
(2001)
Blood
, vol.97
, Issue.10
, pp. 3132-3137
-
-
Koh, C.Y.1
Blazar, B.R.2
George, T.3
-
118
-
-
0027365746
-
Molecular cloning of a ligand for the inducible T cell gene 4-1BB: Amember of an emerging family of cytokines with homology to tumor necrosis factor
-
R. G. Goodwin, W. S. Din, T. Davis-Smith et al., "Molecular cloning of a ligand for the inducible T cell gene 4-1BB: Amember of an emerging family of cytokines with homology to tumor necrosis factor, " European Journal of Immunology, vol. 23, no. 10, pp. 2631-2641, 1993.
-
(1993)
European Journal of Immunology
, vol.23
, Issue.10
, pp. 2631-2641
-
-
Goodwin, R.G.1
Din, W.S.2
Davis-Smith, T.3
-
119
-
-
0031007143
-
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
-
I. Melero, W. W. Shuford, S. A. Newby et al., "Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors, " Nature Medicine, vol. 3, no. 6, pp. 682-685, 1997.
-
(1997)
Nature Medicine
, vol.3
, Issue.6
, pp. 682-685
-
-
Melero, I.1
Shuford, W.W.2
Newby, S.A.3
-
120
-
-
1442324410
-
Role of 4-1BB:4-1BB ligand in cancer immunotherapy
-
A. T. C. Cheuk, G. J. Mufti, and B.-A. Guinn, "Role of 4-1BB:4-1BB ligand in cancer immunotherapy, " Cancer Gene Therapy, vol. 11, no. 3, pp. 215-226, 2004.
-
(2004)
Cancer Gene Therapy
, vol.11
, Issue.3
, pp. 215-226
-
-
Cheuk, A.T.C.1
Mufti, G.J.2
Guinn, B.-A.3
-
121
-
-
17644389199
-
TNF/TNFR family members in costimulation of T cell responses
-
T.H. Watts, "TNF/TNFR family members in costimulation of T cell responses, " Annual Review of Immunology, vol. 23, pp. 23-68, 2005.
-
(2005)
Annual Review of Immunology
, vol.23
, pp. 23-68
-
-
Watts, T.H.1
-
122
-
-
33748286793
-
Dual immunoregulatory pathways of 4-1BB signaling
-
D. S. Vinay, K. Cha, and B. S. Kwon, "Dual immunoregulatory pathways of 4-1BB signaling, " Journal of Molecular Medicine, vol. 84, no. 9, pp. 726-736, 2006.
-
(2006)
Journal of Molecular Medicine
, vol.84
, Issue.9
, pp. 726-736
-
-
Vinay, D.S.1
Cha, K.2
Kwon, B.S.3
-
123
-
-
0034541168
-
Role of TNF receptorassociated factor 2 and p38 mitogen-Activated protein kinase activation during 4-1BB-dependent immune response
-
J. L. Cannons, Y. Choi, and T. H. Watts, "Role of TNF receptorassociated factor 2 and p38 mitogen-Activated protein kinase activation during 4-1BB-dependent immune response, " Journal of Immunology, vol. 165, no. 11, pp. 6193-6204, 2000.
-
(2000)
Journal of Immunology
, vol.165
, Issue.11
, pp. 6193-6204
-
-
Cannons, J.L.1
Choi, Y.2
Watts, T.H.3
-
124
-
-
0036838689
-
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-L and Bfl-1
-
H.-W. Lee, S.-J. Park, B. K. Choi, H.H. Kim, K.-O. Nam, and B. S. Kwon, "4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-L and Bfl-1, " The Journal of Immunology, vol. 169, no. 9, pp. 4882-4888, 2002.
-
(2002)
The Journal of Immunology
, vol.169
, Issue.9
, pp. 4882-4888
-
-
Lee, H.-W.1
Park, S.-J.2
Choi, B.K.3
Kim, H.H.4
Nam, K.-O.5
Kwon, B.S.6
-
125
-
-
0037627478
-
Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering
-
L. Myers, C. Takahashi, R. S. Mittler, R. J. Rossi, and A. T. Vella, "Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5348-5353, 2003.
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.9
, pp. 5348-5353
-
-
Myers, L.1
Takahashi, C.2
Mittler, R.S.3
Rossi, R.J.4
Vella, A.T.5
-
126
-
-
0036083989
-
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
-
O. Martinet, C. M. Divino, Y. Zang et al., "T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer, " Gene Therapy, vol. 9, no. 12, pp. 786-792, 2002.
-
(2002)
Gene Therapy
, vol.9
, Issue.12
, pp. 786-792
-
-
Martinet, O.1
Divino, C.M.2
Zang, Y.3
-
127
-
-
0034218442
-
Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
-
S.-H. Chen, K. B. Pham-Nguyen, O. Martinet et al., "Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation, " Molecular Therapy, vol. 2, no. 1, pp. 39-46, 2000.
-
(2000)
Molecular Therapy
, vol.2
, Issue.1
, pp. 39-46
-
-
Chen, S.-H.1
Pham-Nguyen, K.B.2
Martinet, O.3
-
128
-
-
0035266427
-
Divergent effects of 4-1BB antibodies on antitumor immunity and on tumorreactive T-cell generation
-
J. A. Kim, B. J. Averbook, K. Chambers et al., "Divergent effects of 4-1BB antibodies on antitumor immunity and on tumorreactive T-cell generation, " Cancer Research, vol. 61, no. 5, pp. 2031-2037, 2001.
-
(2001)
Cancer Research
, vol.61
, Issue.5
, pp. 2031-2037
-
-
Kim, J.A.1
Averbook, B.J.2
Chambers, K.3
-
129
-
-
0033938756
-
Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma
-
S. E. Strome, B. Martin, D. Flies et al., "Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma, " Journal of Immunotherapy, vol. 23, no. 4, pp. 430-437, 2000.
-
(2000)
Journal of Immunotherapy
, vol.23
, Issue.4
, pp. 430-437
-
-
Strome, S.E.1
Martin, B.2
Flies, D.3
-
130
-
-
0038181099
-
Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy
-
Q. Li, A. Carr, F. Ito, S. Teitz-Tennenbaum, and A. E. Chang, "Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy, " Cancer Research, vol. 63, no. 10, pp. 2546-2552, 2003.
-
(2003)
Cancer Research
, vol.63
, Issue.10
, pp. 2546-2552
-
-
Li, Q.1
Carr, A.2
Ito, F.3
Teitz-Tennenbaum, S.4
Chang, A.E.5
-
131
-
-
0031906785
-
Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 costimulatory pathway
-
I. Melero, N. Bach, K. E. Hellstrm, A. Aruffo, R. S. Mittler, and L. Chen, "Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 costimulatory pathway, " European Journal of Immunology, vol. 28, no. 3, pp. 1116-1121, 1998.
-
(1998)
European Journal of Immunology
, vol.28
, Issue.3
, pp. 1116-1121
-
-
Melero, I.1
Bach, N.2
Hellstrm, K.E.3
Aruffo, A.4
Mittler, R.S.5
Chen, L.6
-
132
-
-
0033560179
-
4-IBBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
-
B.-A. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein, "4-IBBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine, " The Journal of Immunology, vol. 162, no. 8, pp. 5003-5010, 1999.
-
(1999)
The Journal of Immunology
, vol.162
, Issue.8
, pp. 5003-5010
-
-
Guinn, B.-A.1
DeBenedette, M.A.2
Watts, T.H.3
Berinstein, N.L.4
-
133
-
-
0034536944
-
Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells
-
S. Mogi, J. Sakurai, T. Kohsaka et al., "Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells, " Immunology, vol. 101, no. 4, pp. 541-547, 2000.
-
(2000)
Immunology
, vol.101
, Issue.4
, pp. 541-547
-
-
Mogi, S.1
Sakurai, J.2
Kohsaka, T.3
-
134
-
-
0032823594
-
Expression of Co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity
-
J. Xiang, "Expression of Co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity, " Cancer Biotherapy and Radiopharmaceuticals, vol. 14, no. 5, pp. 353-361, 1999.
-
(1999)
Cancer Biotherapy and Radiopharmaceuticals
, vol.14
, Issue.5
, pp. 353-361
-
-
Xiang, J.1
-
135
-
-
0033602151
-
Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR
-
A. L. Gurney, S. A. Marsters, A. Huang et al., "Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR, " Current Biology, vol. 9, no. 4, pp. 215-218, 1999.
-
(1999)
Current Biology
, vol.9
, Issue.4
, pp. 215-218
-
-
Gurney, A.L.1
Marsters, S.A.2
Huang, A.3
-
136
-
-
0033525904
-
Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand
-
B. Kwon, K.-Y. Yu, J. Ni et al., "Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand, " The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6056-6061, 1999.
-
(1999)
The Journal of Biological Chemistry
, vol.274
, Issue.10
, pp. 6056-6061
-
-
Kwon, B.1
Yu, K.-Y.2
Ni, J.3
-
137
-
-
0036195161
-
CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor
-
R. S. McHugh, M. J. Whitters, C. A. Piccirillo et al., "CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, " Immunity, vol. 16, no. 2, pp. 311-323, 2002.
-
(2002)
Immunity
, vol.16
, Issue.2
, pp. 311-323
-
-
McHugh, R.S.1
Whitters, M.J.2
Piccirillo, C.A.3
-
138
-
-
0036170938
-
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-Tolerance
-
J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, "Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-Tolerance, " Nature Immunology, vol. 3, no. 2, pp. 135-142, 2002.
-
(2002)
Nature Immunology
, vol.3
, Issue.2
, pp. 135-142
-
-
Shimizu, J.1
Yamazaki, S.2
Takahashi, T.3
Ishida, Y.4
Sakaguchi, S.5
-
139
-
-
1642379813
-
Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations
-
S. Ronchetti, O. Zollo, S. Bruscoli et al., "Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations, " European Journal of Immunology, vol. 34, no. 3, pp. 613-622, 2004.
-
(2004)
European Journal of Immunology
, vol.34
, Issue.3
, pp. 613-622
-
-
Ronchetti, S.1
Zollo, O.2
Bruscoli, S.3
-
140
-
-
1842424807
-
Ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis
-
A. P. Kohm, J. S. Williams, and S. D. Miller, "Ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis, " The Journal of Immunology, vol. 172, no. 8, pp. 4686-4690, 2004.
-
(2004)
The Journal of Immunology
, vol.172
, Issue.8
, pp. 4686-4690
-
-
Kohm, A.P.1
Williams, J.S.2
Miller, S.D.3
-
141
-
-
2942532501
-
Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells
-
F. Kanamaru, P. Youngnak, M. Hashiguchi et al., "Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells, " Journal of Immunology, vol. 172, no. 12, pp. 7306-7314, 2004.
-
(2004)
Journal of Immunology
, vol.172
, Issue.12
, pp. 7306-7314
-
-
Kanamaru, F.1
Youngnak, P.2
Hashiguchi, M.3
-
142
-
-
17444414236
-
GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily
-
G. Nocentini and C. Riccardi, "GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily, " European Journal of Immunology, vol. 35, no. 4, pp. 1016-1022, 2005.
-
(2005)
European Journal of Immunology
, vol.35
, Issue.4
, pp. 1016-1022
-
-
Nocentini, G.1
Riccardi, C.2
-
143
-
-
4344608128
-
Constitutive and cytokineinduced GITR ligand expression on human retinal pigment epithelium and photoreceptors
-
B. J. Kim, Z. Li, R. N. Fariss et al., "Constitutive and cytokineinduced GITR ligand expression on human retinal pigment epithelium and photoreceptors, " Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3170-3176, 2004.
-
(2004)
Investigative Ophthalmology and Visual Science
, vol.45
, Issue.9
, pp. 3170-3176
-
-
Kim, B.J.1
Li, Z.2
Fariss, R.N.3
-
144
-
-
33746575650
-
The GITR-GITRL interaction: Co-stimulation or contrasuppression of regulatory activity?
-
E. M. Shevach and G. L. Stephens, "The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?" Nature Reviews Immunology, vol. 6, no. 8, pp. 613-618, 2006.
-
(2006)
Nature Reviews Immunology
, vol.6
, Issue.8
, pp. 613-618
-
-
Shevach, E.M.1
Stephens, G.L.2
-
145
-
-
84897933432
-
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability
-
D. A. Schaer, "GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability, " Cancer Immunology Research, vol. 1, no. 5, pp. 320-331, 2013.
-
(2013)
Cancer Immunology Research
, vol.1
, Issue.5
, pp. 320-331
-
-
Schaer, D.A.1
-
146
-
-
84862769116
-
An immune-Active tumor microenvironment favors clinical response to ipilimumab
-
R.-R. Ji, S. D. Chasalow, L. Wang et al., "An immune-Active tumor microenvironment favors clinical response to ipilimumab, " Cancer Immunology, Immunotherapy, vol. 61, no. 7, pp. 1019-1031, 2012.
-
(2012)
Cancer Immunology, Immunotherapy
, vol.61
, Issue.7
, pp. 1019-1031
-
-
Ji, R.-R.1
Chasalow, S.D.2
Wang, L.3
-
147
-
-
23444462753
-
Role of glucocorticoid-induced TNF receptor family gene (GITR) in collageninduced arthritis
-
S. Cuzzocrea, E. Ayroldi, R. Di Paola et al., "Role of glucocorticoid-induced TNF receptor family gene (GITR) in collageninduced arthritis, " The FASEB Journal, vol. 19, no. 10, pp. 1253-1265, 2005.
-
(2005)
The FASEB Journal
, vol.19
, Issue.10
, pp. 1253-1265
-
-
Cuzzocrea, S.1
Ayroldi, E.2
Di Paola, R.3
-
148
-
-
29744441207
-
Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis
-
M. Patel, D. Xu, P. Kewin et al., "Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis, " European Journal of Immunology, vol. 35, no. 12, pp. 3581-3590, 2005.
-
(2005)
European Journal of Immunology
, vol.35
, Issue.12
, pp. 3581-3590
-
-
Patel, M.1
Xu, D.2
Kewin, P.3
-
149
-
-
84859567294
-
Glucocorticoid-induced TNF receptor-Triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke
-
M. Takata, T. Nakagomi, S. Kashiwamura et al., "Glucocorticoid-induced TNF receptor-Triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke, " Cell Death and Differentiation, vol. 19, no. 5, pp. 756-767, 2012.
-
(2012)
Cell Death and Differentiation
, vol.19
, Issue.5
, pp. 756-767
-
-
Takata, M.1
Nakagomi, T.2
Kashiwamura, S.3
-
150
-
-
77955279163
-
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-Tumor accumulation
-
Article ID e10436
-
A. D. Cohen, D. A. Schaer, C. Liu et al., "Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-Tumor accumulation, " PLoS ONE, vol. 5, no. 5, Article ID e10436, 2010.
-
(2011)
PLoS ONE
, vol.5
, Issue.5
-
-
Cohen, A.D.1
Schaer, D.A.2
Liu, C.3
-
151
-
-
6344279933
-
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ Tcells
-
G. L. Stephens, R. S. McHugh, M. J. Whitters et al., "Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ Tcells, "The Journal of Immunology, vol. 173, no. 8, pp. 5008-5020, 2004.
-
(2004)
The Journal of Immunology
, vol.173
, Issue.8
, pp. 5008-5020
-
-
Stephens, G.L.1
McHugh, R.S.2
Whitters, M.J.3
-
152
-
-
4644342928
-
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
-
M. J. Turk, J.A. Guevara-Patiño, G. A. Rizzuto, M. E. Engelhorn, and A. N. Houghton, "Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells, "The Journal of Experimental Medicine, vol. 200, no. 6, pp. 771-782, 2004.
-
(2004)
The Journal of Experimental Medicine
, vol.200
, Issue.6
, pp. 771-782
-
-
Turk, M.J.1
Guevara-Patiño, J.A.2
Rizzuto, G.A.3
Engelhorn, M.E.4
Houghton, A.N.5
-
153
-
-
84858787656
-
Modulation of GITR for cancer immunotherapy
-
D. A. Schaer, J. T. Murphy, and J. D. Wolchok, "Modulation of GITR for cancer immunotherapy, " Current Opinion in Immunology, vol. 24, no. 2, pp. 217-224, 2012.
-
(2012)
Current Opinion in Immunology
, vol.24
, Issue.2
, pp. 217-224
-
-
Schaer, D.A.1
Murphy, J.T.2
Wolchok, J.D.3
-
154
-
-
67449110979
-
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
-
D.-M. Kuang, Q. Zhao, C. Peng et al., "Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1, " The Journal of Experimental Medicine, vol. 206, no. 6, pp. 1327-1337, 2009.
-
(2009)
The Journal of Experimental Medicine
, vol.206
, Issue.6
, pp. 1327-1337
-
-
Kuang, D.-M.1
Zhao, Q.2
Peng, C.3
-
155
-
-
79959549102
-
Tumorinfiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer
-
J. Krempski, L. Karyampudi, M. D. Behrens et al., "Tumorinfiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer, " The Journal of Immunology, vol. 186, no. 12, pp. 6905-6913, 2011.
-
(2011)
The Journal of Immunology
, vol.186
, Issue.12
, pp. 6905-6913
-
-
Krempski, J.1
Karyampudi, L.2
Behrens, M.D.3
-
156
-
-
77953422225
-
Combination approaches to immunotherapy: The radiotherapy example
-
M. J. Gough and M. R. Crittenden, "Combination approaches to immunotherapy: The radiotherapy example, " Immunotherapy, vol. 1, no. 6, pp. 1025-1037, 2009.
-
(2009)
Immunotherapy
, vol.1
, Issue.6
, pp. 1025-1037
-
-
Gough, M.J.1
Crittenden, M.R.2
-
157
-
-
0032966188
-
The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation
-
E. M. Rosen, S. Fan, S. Rockwell, and I. D. Goldberg, "The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation, " Cancer Investigation, vol. 17, no. 1, pp. 56-72, 1999.
-
(1999)
Cancer Investigation
, vol.17
, Issue.1
, pp. 56-72
-
-
Rosen, E.M.1
Fan, S.2
Rockwell, S.3
Goldberg, I.D.4
-
158
-
-
80051693219
-
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide
-
S. A. Grossman, X. Ye, G. Lesser et al., "Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide, " Clinical Cancer Research, vol. 17, no. 16, pp. 5473-5480, 2011.
-
(2011)
Clinical Cancer Research
, vol.17
, Issue.16
, pp. 5473-5480
-
-
Grossman, S.A.1
Ye, X.2
Lesser, G.3
-
159
-
-
3843124144
-
A sense of danger from radiation
-
W. H. McBride, C.-S. Chiang, J. L. Olson et al., "A sense of danger from radiation, " Radiation Research, vol. 162, no. 1, pp. 1-19, 2004.
-
(2004)
Radiation Research
, vol.162
, Issue.1
, pp. 1-19
-
-
McBride, W.H.1
Chiang, C.-S.2
Olson, J.L.3
-
160
-
-
36849031260
-
Sensors of ionizing radiation effects on the immunological microenvironment of cancer
-
S. Demaria and S. C. Formenti, "Sensors of ionizing radiation effects on the immunological microenvironment of cancer, " International Journal of Radiation Biology, vol. 83, no. 11-12, pp. 819-825, 2007.
-
(2007)
International Journal of Radiation Biology
, vol.83
, Issue.11-12
, pp. 819-825
-
-
Demaria, S.1
Formenti, S.C.2
-
161
-
-
0032485487
-
Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLS
-
M. L. Albert, B. Sauter, and N. Bhardwaj, "Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLS, " Nature, vol. 392, no. 6671, pp. 86-89, 1998.
-
(1998)
Nature
, vol.392
, Issue.6671
, pp. 86-89
-
-
Albert, M.L.1
Sauter, B.2
Bhardwaj, N.3
-
162
-
-
0035988623
-
Immune modulation by ionizing radiation and its implications for cancer immunotherapy
-
E. J. Friedman, "Immune modulation by ionizing radiation and its implications for cancer immunotherapy, " Current Pharmaceutical Design, vol. 8, no. 19, pp. 1765-1780, 2002.
-
(2002)
Current Pharmaceutical Design
, vol.8
, Issue.19
, pp. 1765-1780
-
-
Friedman, E.J.1
-
163
-
-
0034614897
-
Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
-
B. Sauter, M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj, "Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells, " Journal of ExperimentalMedicine, vol. 191, no. 3, pp. 423-433, 2000.
-
(2000)
Journal of ExperimentalMedicine
, vol.191
, Issue.3
, pp. 423-433
-
-
Sauter, B.1
Albert, M.L.2
Francisco, L.3
Larsson, M.4
Somersan, S.5
Bhardwaj, N.6
-
164
-
-
14744292280
-
Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain
-
D. Zagzag, K. Salnikow, L. Chiriboga et al., "Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain, " Laboratory Investigation, vol. 85, no. 3, pp. 328-341, 2005.
-
(2005)
Laboratory Investigation
, vol.85
, Issue.3
, pp. 328-341
-
-
Zagzag, D.1
Salnikow, K.2
Chiriboga, L.3
-
165
-
-
0036569659
-
A functional role of HLA-G expression in human gliomas: An alternative strategy ofimmune escape
-
H. Wiendl, M. Mitsdoerffer, V. Hofmeister et al., "A functional role of HLA-G expression in human gliomas: An alternative strategy ofimmune escape, "TheJournal of Immunology, vol. 168, no. 9, pp. 4772-4780, 2002.
-
(2002)
TheJournal of Immunology
, vol.168
, Issue.9
, pp. 4772-4780
-
-
Wiendl, H.1
Mitsdoerffer, M.2
Hofmeister, V.3
-
166
-
-
33748085015
-
The combination of ionizing radiation and peripheral vaccination produces long-Term survival of mice bearing established invasive GL261 gliomas
-
E.W. Newcomb, S. Demaria, Y. Lukyanov et al., "The combination of ionizing radiation and peripheral vaccination produces long-Term survival of mice bearing established invasive GL261 gliomas, " Clinical Cancer Research, vol. 12, no. 15, pp. 4730-4737, 2006.
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.15
, pp. 4730-4737
-
-
Newcomb, E.W.1
Demaria, S.2
Lukyanov, Y.3
-
167
-
-
12244252335
-
Immunemediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer
-
S. Demaria, N. Kawashima, A. M. Yang et al., "Immunemediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer, " Clinical Cancer Research, vol. 11, no. 2, part 1, pp. 728-734, 2005.
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.2
, pp. 728-734
-
-
Demaria, S.1
Kawashima, N.2
Yang, A.M.3
-
168
-
-
69949085196
-
Fractionated but not single-dose radiotherapy induces an immunemediated abscopal effect when combined with anti-CTLA-4 antibody
-
M. Z. Dewan, A. E. Galloway, N. Kawashima et al., "Fractionated but not single-dose radiotherapy induces an immunemediated abscopal effect when combined with anti-CTLA-4 antibody, " Clinical Cancer Research, vol. 15, no. 17, pp. 5379-5388, 2009.
-
(2009)
Clinical Cancer Research
, vol.15
, Issue.17
, pp. 5379-5388
-
-
Dewan, M.Z.1
Galloway, A.E.2
Kawashima, N.3
-
169
-
-
84904216679
-
Ipilimumab and radiation therapy for melanoma brain metastases
-
A. W. Silk, M. F. Bassetti, B. T. West, C. I. Tsien, and C. D. Lao, "Ipilimumab and radiation therapy for melanoma brain metastases, " Cancer Medicine, vol. 2, no. 6, pp. 899-906, 2013.
-
(2013)
Cancer Medicine
, vol.2
, Issue.6
, pp. 899-906
-
-
Silk, A.W.1
Bassetti, M.F.2
West, B.T.3
Tsien, C.I.4
Lao, C.D.5
-
170
-
-
84859629008
-
Adult glioblastoma multiforme survival in the temozolomide era: A populationbased analysis of surveillance, epidemiology, and end results registries
-
A. S. Darefsky, J. T. King Jr., and R. Dubrow, "Adult glioblastoma multiforme survival in the temozolomide era: A populationbased analysis of surveillance, epidemiology, and end results registries, " Cancer, vol. 118, no. 8, pp. 2163-2172, 2012.
-
(2012)
Cancer
, vol.118
, Issue.8
, pp. 2163-2172
-
-
Darefsky, A.S.1
King, J.T.2
Dubrow, R.3
-
171
-
-
84908563697
-
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): A multicentre, randomised, openlabel, phase 3 trial
-
R. Stupp, M. E. Hegi, T. Gorlia et al., "Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): A multicentre, randomised, openlabel, phase 3 trial, "TheLancetOncology, vol. 15, no. 10, pp. 1100-1108, 2014.
-
(2014)
TheLancetOncology
, vol.15
, Issue.10
, pp. 1100-1108
-
-
Stupp, R.1
Hegi, M.E.2
Gorlia, T.3
-
172
-
-
0028074499
-
Lymphocyte depletion during treatment with intensive chemotherapy for cancer
-
C. L. Mackall, T. A. Fleisher, M. R. Brown et al., "Lymphocyte depletion during treatment with intensive chemotherapy for cancer, " Blood, vol. 84, no. 7, pp. 2221-2228, 1994.
-
(1994)
Blood
, vol.84
, Issue.7
, pp. 2221-2228
-
-
Mackall, C.L.1
Fleisher, T.A.2
Brown, M.R.3
-
173
-
-
1442283179
-
Selective CD4+ lymphopenia inmelanoma patients treated with temozolomide: A toxicity with therapeutic implications
-
Y. B. Su, S. Sohn, S. E. Krown et al., "Selective CD4+ lymphopenia inmelanoma patients treated with temozolomide: A toxicity with therapeutic implications, " Journal of Clinical Oncology, vol. 22, no. 4, pp. 610-616, 2004.
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.4
, pp. 610-616
-
-
Su, Y.B.1
Sohn, S.2
Krown, S.E.3
-
174
-
-
70450185084
-
Immunotherapy combined with chemotherapy in the treatment of tumors
-
J. L. Frazier, J. E. Han, M. Lim, and A. Olivi, "Immunotherapy combined with chemotherapy in the treatment of tumors, " Neurosurgery Clinics ofNorth America, vol. 21, no. 1, pp. 187-194, 2010.
-
(2011)
Neurosurgery Clinics OfNorth America
, vol.21
, Issue.1
, pp. 187-194
-
-
Frazier, J.L.1
Han, J.E.2
Lim, M.3
Olivi, A.4
-
175
-
-
34547838615
-
Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model
-
S. Brem, B. Tyler, K. Li et al., "Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model, " Cancer Chemotherapy and Pharmacology, vol. 60, no. 5, pp. 643-650, 2007.
-
(2007)
Cancer Chemotherapy and Pharmacology
, vol.60
, Issue.5
, pp. 643-650
-
-
Brem, S.1
Tyler, B.2
Li, K.3
-
176
-
-
84883445769
-
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
-
S. Fritzell, E. Sandn, S. Eberstal, E. Visse, A. Darabi, and P. Siesj, "Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion, " Cancer Immunology, Immunotherapy, vol. 62, no. 9, pp. 1463-1474, 2013.
-
(2013)
Cancer Immunology, Immunotherapy
, vol.62
, Issue.9
, pp. 1463-1474
-
-
Fritzell, S.1
Sandn, E.2
Eberstal, S.3
Visse, E.4
Darabi, A.5
Siesj, P.6
-
177
-
-
68549112974
-
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
-
C. Banissi, F. Ghiringhelli, L. Chen, and A. F. Carpentier, "Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model, " Cancer Immunology, Immunotherapy, vol. 58, no. 10, pp. 1627-1634, 2009.
-
(2009)
Cancer Immunology, Immunotherapy
, vol.58
, Issue.10
, pp. 1627-1634
-
-
Banissi, C.1
Ghiringhelli, F.2
Chen, L.3
Carpentier, A.F.4
|